BMN 190 recombinant human tripeptidyl peptidase-1 (rhTPP1)
190-203
Phase 2 mab completed
Quick answer
BMN 190 recombinant human tripeptidyl peptidase-1 (rhTPP1) for Jansky-Bielschowsky Disease is a Phase 2 program (mab) at BioMarin International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Jansky-Bielschowsky Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- completed